Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 17 Apr 2022 |
2 | Journal Copy | 29 Aug 2022 |
3 | TM-O(NOTICE OF OPPOSITION) | 10 Oct 2022 |
4 | TM-O(NOTICE OF OPPOSITION) | 02 Nov 2022 |
5 | Annexure -1 under rule 46 | 05 Jun 2023 |
5 | Evidence Affidavit Under Rule 46 (TOP) | 05 Jun 2023 |
6 | Evidence Affidavit Under Rule 46 (TOP) | 05 Jun 2023 |
7 | Annexure -1 under rule 46 | 05 Jun 2023 |
7 | Evidence Affidavit Under Rule 46 (TOP) | 05 Jun 2023 |
8 | Annexure -1 under rule 46 | 05 Jun 2023 |
8 | Evidence Affidavit Under Rule 46 (TOP) | 05 Jun 2023 |
1 | Opposition Notice | 14459246 | 5792887 | 09 Dec 2022 |
2 | Opposition Notice | 14520432 | 5804337 | 21 Dec 2022 |
3 | Opposition Counter Statement | 14788906 | 5860625 | 13 Feb 2023 |
4 | Opposition Counter Statement | 14847208 | 5871488 | 23 Feb 2023 |
The application for Pazoxxil was made on 17 April 2022.
The trademark applicant for Pazoxxil is CELON LABORATORIES.
Pazoxxil is applied in class(es) 5.
Application for Pazoxxil is on Opposed stage.
Application Id allotted to Pazoxxil is 5412477.
Trademark agent or attorney for the application is I Sreenivasa Murthy.
Pazoxxil filed with the Intellectual property office as a WORD.